HomeCERO • NASDAQ
add
CERo Therapeutics Holdings Inc
Previous close
$5.50
Day range
$5.30 - $5.65
Year range
$4.27 - $895.40
Market cap
6.51M USD
Avg Volume
218.94K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.43M | 5.49% |
Net income | -5.42M | -121.24% |
Net profit margin | — | — |
Earnings per share | -61.71 | — |
EBITDA | -5.36M | -6.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 3.30M | -9.44% |
Total assets | 6.20M | -15.85% |
Total liabilities | 7.84M | -20.47% |
Total equity | -1.63M | — |
Shares outstanding | 1.21M | — |
Price to book | -0.64 | — |
Return on assets | -191.32% | — |
Return on capital | -4,884.81% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.42M | -121.24% |
Cash from operations | -4.62M | -30.70% |
Cash from investing | — | — |
Cash from financing | 2.72M | 5.06% |
Net change in cash | -1.90M | -100.92% |
Free cash flow | -2.89M | 46.30% |
About
Founded
2020
Headquarters
Website
Employees
8
